ID   NCC-MLPS2-C1
AC   CVCL_C1GI
DR   Wikidata; Q114312460
RX   PubMed=35637403;
WW   Provider; BizCom; -; https://en.cellline.jp/product/ncc-mlps2-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 59 hours (PubMed=35637403).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2726; DDIT3 + HGNC; HGNC:4010; FUS; Name(s)=FUS-DDIT3, TLS-CHOP (PubMed=35637403).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Right thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=35637403
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 8
ST   D16S539: 10,11
ST   D21S11: 30
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C27781; Myxoid liposarcoma
DI   ORDO; Orphanet_99967; Myxoid/round cell liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
RX   PubMed=35637403; DOI=10.1007/s13577-022-00717-1;
RA   Noguchi R., Yoshimatsu Y., Sin Y., Tsuchiya R., Ono T., Akiyama T.,
RA   Hirabayashi K., Ozawa I., Nakagawa R., Kikuta K., Kondo T.;
RT   "Establishment and characterization of two novel patient-derived
RT   myxoid liposarcoma cell lines.";
RL   Hum. Cell 35:1279-1289(2022).
//